Machine signal
Active cluster sell — 4 distinct insiders, $10.3M, window ends Sep 9, 2026.
Figures computed from official regulatory filings — .
Analysttarget 19 USD (+253%) · consensus 4.75/5 · 7 buy · 1 hold · 0 sell
Ownershipinsiders 12.24% · institutions 82.11% · short 10.9% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Entrada Therapeutics, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle, therapeutic candidates are based on a novel therapeutic; a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases. Its preclinical product includes ENTR-601-44; ENTR-601-45; and VX-670. The company was formerly known as CycloPorters, Inc., and changed its name to Entrada Therapeutics, Inc., in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
60 buys217 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| MPM BIOVENTURES 2018, L.P. | Sell | $273.7K | SEC |
| MPM BioVentures 2014, L.P. | Sell | $205.6K | SEC |
| MPM BioVentures 2014, L.P. | Sell | $1.4M | Unusual size | SEC |
| MPM BIOVENTURES 2018, L.P. | Sell | $1.4M | Unusual size | SEC |
| MPM BioVentures 2014, L.P. | Sell | $273.7K | SEC |
| MPM BIOVENTURES 2018, L.P. | Sell | $205.6K | SEC |
| MPM BioVentures 2014, L.P. | Sell | $180.7K | SEC |
| WENTWORTH KORY JAMES | Other | $12.4K | SEC |
| Sethuraman Natarajan | Other | $14.9K | SEC |
| MPM BioVentures 2014, L.P. | Sell | $205.4K | SEC |
| MPM BIOVENTURES 2018, L.P. | Sell | $205.4K | SEC |
| Dowden Nathan J | Other | $18.1K | SEC |
| MPM BIOVENTURES 2018, L.P. | Sell | $231.3K | SEC |
| Doshi Dipal | Other | $62.3K | SEC |
| MPM BIOVENTURES 2018, L.P. | Sell | $180.7K | SEC |
| MPM BioVentures 2014, L.P. | Sell | $231.3K | SEC |
| MPM BIOVENTURES 2018, L.P. | Sell | $26.2K | SEC |
| MPM BIOVENTURES 2018, L.P. | Sell | $280.2K | SEC |
| MPM BioVentures 2014, L.P. | Sell | $280.2K | SEC |
| MPM BIOVENTURES 2018, L.P. | Sell | $309.4K | SEC |
| MPM BioVentures 2014, L.P. | Sell | $26.2K | SEC |
| MPM BioVentures 2014, L.P. | Sell | $309.4K | SEC |
| MPM BIOVENTURES 2018, L.P. | Sell | $102.9K | SEC |
| MPM BioVentures 2014, L.P. | Sell | $102.9K | SEC |
| MPM BioVentures 2014, L.P. | Sell | $158.7K | SEC |